首页|Therapeutic Role of Chinese Medicine Targeting Nrf2/HO-1 Signaling Pathway in Myocardial Ischemia/Reperfusion Injury

Therapeutic Role of Chinese Medicine Targeting Nrf2/HO-1 Signaling Pathway in Myocardial Ischemia/Reperfusion Injury

扫码查看
Acute myocardial infarction(AMI),characterized by high incidence and mortality rates,poses a significant public health threat.Reperfusion therapy,though the preferred treatment for AMI,often exacerbates cardiac damage,leading to myocardial ischemia/reperfusion injury(MI/RI).Consequently,the development of strategies to reduce MI/RI is an urgent priority in cardiovascular therapy.Chinese medicine,recognized for its multi-component,multi-pathway,and multi-target capabilities,provides a novel approach for alleviating MI/RI.A key area of interest is the nuclear factor E2-related factor 2(Nrf2)/heme oxygenase-1(HO-1)pathway.This pathway is instrumental in regulating inflammatory responses,oxidative stress,apoptosis,endoplasmic reticulum stress,and ferroptosis in MI/RI.This paper presents a comprehensive overview of the Nrf2/HO-1 signaling pathway's structure and its influence on MI/RI.Additionally,it reviews the latest research on leveraging Chinese medicine to modulate the Nrf2/HO-1 pathway in MI/RI treatment.

nuclear factor E2-related factor 2/heme oxygenase-1 signaling pathwaymyocardial ischemia/reperfusion injuryChinese medicinemechanisms

LIU Chang-xing、GUO Xin-yi、ZHOU Ya-bin、WANG He

展开 >

First Clinical Medical School,Heilongjiang University of Chinese Medicine,Harbin(150040),China

Clinical Medical School,Chengdu University of Traditional Chinese Medicine,Chengdu(610036),China

Department of Cardiology,the First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin(150040),China

Talent Project of Education Department of Heilongjiang Province

15011220094

2024

中国结合医学杂志(英文版)
中国中西医结合学会 中国中医研究院

中国结合医学杂志(英文版)

CSTPCD
影响因子:1.056
ISSN:1672-0415
年,卷(期):2024.30(10)